part_subject: "INVESTIGATIONAL NEW DRUG APPLICATION"
subpart_code: "E"
subpart_subject: "Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses"
section_number: "312.87"
section_subject: "Active monitoring of conduct and evaluation of clinical trials."
cfr_reference: "21 CFR 312.87"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 300 to 499"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
For drugs covered under this section, the Commissioner and other agency officials will monitor the progress of the conduct and evaluation of clinical trials and be involved in facilitating their appropriate progress.